Rare diseases
Investigational molecules
Locations
Back to Poland33 clinical trials in Biala Podlaska, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Efficacy and Safety of Once‑Daily Oral ASC30 in Adults with Obesity or Overweight: A Phase III Randomized Placebo‑Controlled Trial
PolandA Phase III Study of ASC30 Sodium for Weight Loss in Adults with Obesity or Overweight and Type 2 Diabetes
PolandPolandStudy on Long-term Safety of Nivolumab and Drug Combination for Cancer Patients from Previous BMS Trials
PolandStudy of ziftomenib with drug combinations for adults with newly diagnosed acute myeloid leukemia with NPM1 or KMT2A genetic changes
PolandStudy of Izalontamab Brengitecan Compared to Standard Chemotherapy in Untreated Triple-negative or ER-low, HER2-negative Breast Cancer Patients Not Eligible for Anti-PD1/PD-L1 Treatment
PolandStudy on CDR132L for Heart Failure with Reduced Ejection Fraction and Left Ventricular Hypertrophy in Adults
PolandStudy Comparing Amivantamab and Drug Combination for Patients with Recurrent or Metastatic Colorectal Cancer Without KRAS/NRAS and BRAF Mutations
PolandStudy of Lisaftoclax Alone or with Drug Combination for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
PolandStudy on the Effectiveness and Safety of Saruparib and Camizestrant in Adults with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
PolandStudy on Zanidatamab and Chemotherapy for Patients with Metastatic HER2-Positive Breast Cancer After Trastuzumab Deruxtecan Treatment
PolandStudy Comparing Pirtobrutinib and Ibrutinib for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on heart failure prevention and treatment, including studies evaluating new combination therapies with drugs like baxdrostat and dapagliflozin. Research also encompasses atrial fibrillation management strategies.
Studies aim to reduce cardiovascular mortality and improve patient outcomes through targeted therapeutic approaches.
Comprehensive research in various cancer types, including colorectal cancer, breast cancer, and lung cancer. Trials evaluate novel treatment combinations and targeted therapies for both early-stage and metastatic disease.
Focus on developing personalized treatment approaches and improving survival outcomes across multiple cancer types.
Groundbreaking studies in blood disorders, particularly leukemia and multiple myeloma. Research includes novel combination therapies and treatment strategies for both newly diagnosed and relapsed/refractory cases.
Trials aim to improve treatment outcomes and develop more effective therapeutic options for patients with blood cancers.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
